In mouse models of AIDs such as MS and T1D, among others, knockout of key factors including IFN-γ, IL-17, T-bet, Rel, or RORγt does not consistently attenuate disease progression and may even exacerbate it. Here, IL17A is linked to myeloid sarcoma.